The incidence of prostate cancer among South African men is just as significant as it is worldwide [1,2].
Although the role of the prostate cancer antigen 3 (PCA3) assay in predicting biopsy outcome has proven
beneficial in a South African context , the assessment of its role incorporated into a prostate cancer risk
calculator has not yet been explored on the continent of Africa. We aimed to assess the performance of the
PCA3-incorporated Chun nomogram  and to compare its performance with other contemporary risk